From Surf Wiki (app.surf) — the open knowledge base
DMCPA
| Field | Value | |||
|---|---|---|---|---|
| Verifiedfields | verified | |||
| verifiedrevid | 477222551 | |||
| drug_name | DMCPA | |||
| image | DMCPA.svg | |||
| image_class | skin-invert-image | |||
| width | 200px | |||
| image2 | DMCPA-3d-sticks.png | |||
| image_class2 | bg-transparent | |||
| width2 | 175px | |||
| routes_of_administration | Oral | |||
| class | Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen | |||
| ATC_prefix | None | |||
| CAS_number_Ref | ||||
| CAS_number | 714903-64-7 | |||
| PubChem | 3017965 | |||
| ChemSpiderID_Ref | ||||
| ChemSpiderID | 2285590 | |||
| UNII_Ref | ||||
| UNII | U2YC8RFK7B | |||
| ChEMBL_Ref | ||||
| ChEMBL | 13530 | |||
| synonyms | 25D-CPA; 2,5-Dimethoxy-4-methylphenylcyclopropylamine | |||
| IUPAC_name | 2-(2,5-dimethoxy-4-methylphenyl)cyclopropan-1-amine | |||
| C | 12 | H=17 | N=1 | O=2 |
| SMILES | O(c1c(cc(OC)c(c1)C2CC2N)C)C | |||
| StdInChI_Ref | ||||
| StdInChI | 1S/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3 | |||
| StdInChIKey_Ref | ||||
| StdInChIKey | HYVPPECPQRBJEQ-UHFFFAOYSA-N |
| Drugs.com =
| elimination_half-life =
2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-known psychedelic drug and a substituted amphetamine and phenylcyclopropylamine.
Use and effects
In Alexander Shulgin's book PiHKAL (Phenethylamines I Have Known and Loved), the dose range is listed as 15 to 20mg and the duration is listed as 4 to 8hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. One of the reports in PiHKAL gave it a +++ on the Shulgin Rating Scale.
Interactions
Pharmacology
Pharmacodynamics
The comprehensive receptor interactions of DMCPA have been studied.
History
DMCPA was first described in the scientific literature by at least 1974.
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
References
References
- [http://www.erowid.org/library/books_online/pihkal/pihkal056.shtml DMCPA Entry in ''PiHKAL'']
- (July 2025). "The polypharmacology of psychedelics reveals multiple targets for potential therapeutics". Neuron.
- (October 1974). "Structure-activity relationships in psychotomimetic phenylalkylamines". J Med Chem.
- "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about DMCPA — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report